Bracco Diagnostics, Inc. Recalls CardioGen-82

August 4, 2011

As a precaution, Bracco Diagnostics, Inc. asks that clinicians immediately stop using CardioGen-83 and voluntarily initiated a recall after recently receiving reports of two patients who had received more radiation than expected due to strontium isotopes which may have been inadvertently injected due to a “strontium breakthrough” problem with CardioGen-82.